Study Suggests Weight Loss Injections May Help Prevent Cancer
Weight loss jabs 'should be probed as cancer prevention agents' after US study
Image: Mirror
A recent study indicates that weight loss injections like Mounjaro, Wegovy, and Ozempic may reduce the risk of obesity-related cancers by 41% in non-diabetic obese patients. Experts advocate for further investigation into these medications as potential cancer prevention agents.
- 01The study involved over 161,000 obese patients without diabetes, with half using weight-loss injections.
- 02Participants using GLP-1 medications showed a 41% lower risk of obesity-related cancers over two years.
- 03Men experienced nearly a 70% reduction in cancer risk, while a 58% reduction was noted for endometrial cancer.
- 04The findings suggest that GLP-1 medications could transform cancer prevention strategies, particularly for those already prescribed these drugs.
- 05Further research is necessary to confirm these findings and explore the broader health impacts of GLP-1 medications.
Advertisement
In-Article Ad
Experts are calling for further investigation into weight loss injections, such as Mounjaro, Wegovy, and Ozempic, as potential cancer prevention agents. A recent study published in the Annals of Oncology analyzed data from over 161,000 obese patients who did not have diabetes or obesity-related cancers. The research found that those using GLP-1 receptor agonists (GLP-1 RAs) had a 41% lower risk of being diagnosed with obesity-related cancers over an average follow-up of two years. Notably, men saw a nearly 70% reduction in risk, and there was a 58% decrease in endometrial cancer incidence. However, this reduction was not observed among black patients, possibly due to various factors including access to care and biological differences. Senior author Dr. Aparna Kamat emphasized the need for further studies to explore the cancer prevention potential of GLP-1 medications, highlighting their growing use and the importance of understanding their broader health impacts.
Advertisement
In-Article Ad
The findings suggest that GLP-1 medications could reshape treatment approaches for obesity and cancer prevention, particularly in adults in their 40s and 50s.
Advertisement
In-Article Ad
Reader Poll
Do you believe weight loss medications should be investigated for cancer prevention?
Connecting to poll...
Read the original article
Visit the source for the complete story.